Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;68(3):351-6.
doi: 10.1001/archneurol.2011.31.

Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment

Affiliations

Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment

Robert S Wilson et al. Arch Neurol. 2011 Mar.

Abstract

Objective: To characterize the course of cognitive decline during the prodromal phase of Alzheimer disease.

Design: Longitudinal cohort study with up to 16 years of observation.

Participants: Older persons from 2 studies underwent annual clinical evaluations that included cognitive function testing and clinical classification of mild cognitive impairment, dementia, and Alzheimer disease. At baseline, there were 2071 individuals without dementia and 1511 without cognitive impairment.

Results: During follow-up, 462 persons developed Alzheimer disease (20 with dementia solely due to another condition were excluded). Five to six years before diagnosis, the rate of global cognitive decline accelerated more than 15-fold. The acceleration in cognitive decline occurred slightly earlier for semantic memory (76 months before diagnosis) and working memory (75 months) than other cognitive functions. Mild cognitive impairment was also preceded by years of cognitive decline that began earlier (80 months before diagnosis) and proceeded more rapidly (annual loss of 0.102 unit) in the amnestic than in the nonamnestic (62 months, 0.072 unit) subtype.

Conclusion: Dementia due to Alzheimer disease is preceded by about 5 to 6 years of accelerated decline in multiple cognitive functions. By contrast, little decline is evident in persons who do not develop Alzheimer disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Global Cognitive Decline Before and After Dementia Onset in Alzheimer's Disease. Predicted 10-year paths of decline in global cognition for typical participants who remained dementia free (solid line) or developed AD in study year 7 (dashed line), adjusted for age, sex, and education.
Figure 2
Figure 2
Decline in Specific Cognitive Functions Before and After Dementia Onset in Alzheimer's Disease. Predicted 10-year paths of cognitive decline for typical participants who remained dementia free (solid line) or developed AD in study year 7 (dashed line), adjusted for age, sex, and education.
Figure 3
Figure 3
Global Cognitive Decline Before and After Onset of Amnestic (upper panel) or Nonamnestic (lower panel) Mild Cognitive Impairment. Predicted 10-year paths of decline in global cognition for typical participants whose cognition remained intact (solid line) or became impaired in study year 8 (dashed line), adjusted for age, sex, and education.

References

    1. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Pub Health. 1998;88:1337–1342. - PMC - PubMed
    1. Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Ann Rev Pub Health. 2002;23:213–231. - PubMed
    1. Hall CB, Lipton RB, Sliwinski M, Stewart WF. A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med. 2000;19:1555–1566. - PubMed
    1. Amieva H, Jacqmin-Gadda H, Orgogozo JM, et al. The 9 year cognitive decline before dementia of Alzheimer type: a prospective population-based study. Brain. 2005;128:1093–1101. - PubMed
    1. Amieva H, LeGaff M, Millet X, et al. Prodromal Alzheimer's disease: successive emergence of clinical symptoms. Ann Neurol. 2008;64:492–498. - PubMed

Publication types